Skip To Main Content
M. Bartoletti on Muck Rack

M. Bartoletti

As seen in: Cancer Treatment Reviews
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with M.

Contact M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors

|
By Byers Lauren Averett, M. Bartoletti, L. Musacchio, G. Giannone
| Cancer Treatment Reviews Verified
Highlights • PARP inhibitors have opened the era of targeted therapy in ovarian cancer; • Major therapeutic improvements have been limited to the high grade serous subtype; • The panorama of possible clinically actionable targets in ovarian cancer is wider. • New druggable alterations and matched drugs are under investigation.
Open in Who Shared Issue with article?
See all 1 articles